A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer
Yanli Liu(National Medical Products Administration), Xiaoyang Zhang(University of Utah), Andrew D. Cherniack(Broad Institute), Zhong Wu(Nanfang Hospital), Jason Gertz(University of Utah), Swneke D. Bailey(McGill University Health Centre), Xiaojun Yang(Northwest A&F University), Xingdong Chen(Fudan University), Estrella Aguilera-Jimenez(Huntsman Cancer Institute), Jin Zhou(The University of Texas Southwestern Medical Center), Dinesh K. A. Ramadurai(University of Utah), Katherine E. Varley(University of Utah), Alison M. Taylor(Broad Institute), Adam J. Bass(Dana-Farber Cancer Institute), Katelyn L. Mortenson(University of Utah), Yifei Yan(McGill University Health Centre), Peter S. Choi(Children's Hospital of Philadelphia)
Cited by 50
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Comprehensive molecular profiling of lung adenocarcinoma
|Nature|2014|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k